Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316836 · ClinicalTrials.gov registry record
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 554
- Enrollment target
NCT00316836 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 554 participants.
The verdict
NCT00316836 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 554 participants
- Enrollment target
Study Summary
RATIONALE: Understanding the relationship between breast density, levels of hormones in the blood, and levels of anticancer drugs in the blood may help improve the ability to plan effective treatment for women with invasive breast cancer. PURPOSE: This clinical trial is studying the relationship between breast density and blood levels of hormones and anticancer drugs in women with invasive breast cancer who are receiving exemestane or anastrozole.
Interventions
- PROCEDURE mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 554 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00316836
The ClinicalTrials.gov registry entry for NCT00316836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mammography is the first listed.
NCT00316836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00316836 about?
NCT00316836 is a clinical study titled "Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole". RATIONALE: Understanding the relationship between breast density, levels of hormones in the blood, and levels of anticancer drugs in the blood may help improve the ability to plan effective treatment for women with invasive breast cancer. PURPOSE: This clinical trial is studying the relationship be...
What is the current status of trial NCT00316836?
This trial is currently completed. The enrollment target is 554 participants. The study started on 2006-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00316836?
The interventions under investigation include: mammography (PROCEDURE).
Who is sponsoring clinical trial NCT00316836?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.